Skip to content

Iron Supplementation Among Low-Income Postpartum Women

Phase 3 Study of the Prevention of Postpartum Anemia by Three Different Strategies

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00207610
Enrollment
959
Registered
2005-09-21
Start date
2003-06-30
Completion date
2007-09-30
Last updated
2009-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia

Keywords

Anemia, Postpartum, iron, supplements

Brief summary

Anemia is common among low-income women after they have given birth. Anemia, or low hemoglobin in the blood cells, is usually caused by not having enough iron. Blood cells usually carry oxygen to other parts of the body. Without enough hemoglobin, the ability of blood cells to carry oxygen is decreased. Memory and work may be impaired. The purpose of this study is to evaluate three methods of giving iron to prevent anemia among low-income women after they have given birth.

Detailed description

Currently the Centers for Disease Control and Prevention recommendations to prevent iron deficiency advocate selective screening and treatment of anemia at about 6 weeks postpartum. However, among some groups, such as low income women, data suggest that anemia and iron deficiency are common. This study aims to evaluate the effectiveness of three stategies to prevent iron deficiency among low income postpartum women in Mississippi. Comparisons: Clinics will be randomized to one of three strategies: 1)Selective anemia screening and treatment of anemic women, 2)universal anemia screening and treatment of anemic women, or 3)universal iron supplementation of 65 mg a day for three months.

Interventions

BEHAVIORALDaily iron supplements of 65 mg a day for 3 months
BEHAVIORALUniversal anemia screening and treatment
BEHAVIORALSelective anemia screening and treatment

Sponsors

Centers for Disease Control and Prevention
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
13 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* postpartum girls and women, 2-6 weeks after birth * age 13 years or more * WIC certified

Exclusion criteria

* sickle cell anemia * Hemoglobin \< 7 g/dL

Design outcomes

Primary

MeasureTime frame
anemia6 months postpartum

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026